Clinical Trials Logo
  1. Home
  2. Pervasive Developmental Disorder
  3. NCT00870727

Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders

Pervasive Developmental Disorder Clinical Trial

Official title:
Pharmacotherapy of Pervasive Developmental Disorders

Clinical Trial Summary

The purpose of this study is to develop a better tolerated and more effective pharmacologic treatment with individuals with Pervasive Developmental Disorder. This is a double-blind, placebo-controlled study of aripiprazole in the management of the maladaptive behaviors of Pervasive Developmental Disorder. The investigators hypothesize that aripiprazole will be more effective than placebo for reducing aggression, tantrum and self-injurious behavior in children with Pervasive Developmental Disorder.

Clinical Trial Description

Pervasive developmental disorders (PDDs) are characterized by severe impairments in social interaction and communication in addition to restricted patterns of interests and activities. Research suggests that a dysregulation of the dopamine and serotonin systems contributes to these interfering behaviors in individuals with PDD. After benefits of typical neuroleptics were reported in subjects with PDD, research shifted to the atypical antipsychotics which have been shown to be better tolerated and effective in this population. However, the atypical antipsychotics have also been associated with adverse effects. Thus there remains a need for a novel pharmacotherapy that would be safe and effective for children and adolescents with PDDs. The primary objectives of this study are to determine whether aripiprazole is effective and well tolerated for irritability in children and adolescents with PDD not otherwise specified (NOS) during an 8-week acute phase and whether the effectiveness and tolerability of aripiprazole is maintained during a 16-week continuation phase. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00870727
Study type Interventional
Source Indiana University
Contact
Status Completed
Phase Phase 3
Start date February 2009
Completion date May 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01243905 - Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders Phase 2/Phase 3
Not yet recruiting NCT00531830 - Assessment of Factors Which Predict Improvement in Children With PDD After a Year of Integrative Therapy N/A
Completed NCT02985749 - A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder Phase 3
Terminated NCT00325572 - Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism Phase 1
Completed NCT00399698 - Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. Phase 3
Completed NCT03177590 - Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project N/A
Recruiting NCT05664841 - The Impact of a Virtual Magic Trick Training Program Phase 2
Active, not recruiting NCT02199925 - An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum Phase 4
Terminated NCT01553240 - Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies N/A
Completed NCT00464477 - Advanced Grandparental Age as a Risk Factor for Autism N/A
Active, not recruiting NCT03170453 - Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder N/A
Completed NCT00773812 - Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders Phase 1
Completed NCT01808066 - GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs N/A
Completed NCT00198055 - A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. Phase 2
Completed NCT00308074 - An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders Phase 2
Completed NCT00579267 - Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) N/A
Completed NCT04788537 - Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders N/A
Recruiting NCT04654260 - Behavior Therapy for Irritability in Autism N/A
Completed NCT01921244 - Shared Decision Making to Improve Care and Outcomes for Children With Autism N/A
Completed NCT00902798 - Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder N/A